Molecular mediators of macrophage fusion

被引:250
作者
Helming, Laura [1 ]
Gordon, Siamon [2 ,3 ]
机构
[1] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany
[2] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
[3] NCI, NIH, Frederick, MD 21701 USA
基金
英国医学研究理事会;
关键词
GIANT-CELL FORMATION; TETRASPANINS CD9; DC-STAMP; ALTERNATIVE ACTIVATION; CUTTING EDGE; IN-VITRO; OSTEOCLAST; CD81; RECEPTOR; PHOSPHATIDYLSERINE;
D O I
10.1016/j.tcb.2009.07.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Fusion of macrophages leads to the formation of osteoclasts in bone and of multinucleated giant cells in granulomas. The precise function of granuloma-associated multinucleates giant cells is not clear but substantial progress has recently been made in identifying the molecular machinery involved in macrophage fusion. Signaling processes mediated by DAP12 and STAT6 induce a fusion-competent status. Chemotaxis through CCL2, cell-cell adhesion mediated by E-cadherin, exposure of phosphatidylserine, lipid recognition by CD36 and cytoskeletal rearrangements depending on RAC1 are prerequisites for successful macrophage fusion. We review current knowledge on the molecular mediators of giant cell formation, compare giant cells with osteoclasts and highlight key target areas for future research and medical relevance.
引用
收藏
页码:514 / 522
页数:9
相关论文
共 54 条
[1]   αvβ5 integrin recruits the Crkll-Dock180-Rac1 complex for phagocytosis of apoptotic cells [J].
Albert, ML ;
Kim, JI ;
Birge, RB .
NATURE CELL BIOLOGY, 2000, 2 (12) :899-905
[2]   B-1 cells are pivotal for in vivo inflammatory giant cell formation [J].
Bogsan, CSB ;
Brito, RRNE ;
Palos, MD ;
Mortara, RA ;
Almeida, SR ;
Lopes, JD ;
Mariano, M .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2005, 86 (04) :257-265
[3]  
Bühling F, 2001, J PATHOL, V195, P375
[4]   Unveiling the mechanisms of cell-cell fusion [J].
Chen, EH ;
Olson, EN .
SCIENCE, 2005, 308 (5720) :369-373
[5]   Langerhans cell histiocytosis reveals a new IL-17A dependent pathway of dendritic cell fusion [J].
Coury, Fabienne ;
Annels, Nicola ;
Rivollier, Aymeric ;
Olsson, Selma ;
Santoro, Alessandra ;
Speziani, Carole ;
Azocar, Olga ;
Flacher, Monique ;
Djebali, Sophia ;
Tebib, Jacques ;
Brytting, Maria ;
Egeler, R. Maarten ;
Rabourdin-Combe, Chantal ;
Henter, Jan-Inge ;
Arico, Maurizio ;
Delprat, Christine .
NATURE MEDICINE, 2008, 14 (01) :81-87
[6]   Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis [J].
da Costa, CET ;
Annels, NE ;
Faaij, CMJM ;
Forsyth, RG ;
Hogendoorn, PCW ;
Egeler, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :687-693
[7]  
DUCLLI D, 2007, NAT REV CANCER, V7, P968
[8]   Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4 [J].
Fernandez-Boyanapalli, Ruby F. ;
Frasch, S. Courtney ;
McPhillips, Kathleen ;
Vandivier, R. William ;
Harry, Brian L. ;
Riches, David W. H. ;
Henson, Peter M. ;
Bratton, Donna L. .
BLOOD, 2009, 113 (09) :2047-2055
[9]   Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells [J].
Greenberg, Michael E. ;
Sun, Mingjiang ;
Zhang, Renliang ;
Febbraio, Maria ;
Silverstein, Roy ;
Hazen, Stanley L. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (12) :2613-2625
[10]   Cutting edge: Inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12 [J].
Hamerman, Jessica A. ;
Jarjoura, Vessica R. ;
Humphrey, Mary Beth ;
Nakamura, Mary C. ;
Seaman, William E. ;
Lanier, Lewis L. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (04) :2051-2055